share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

SEC announcement ·  Jun 29 05:19
Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.